Prostate cancer > https://phgkb.cdc.gov/GAPPKB/phgHome.do < Prostate cancer

https://phgkb.cdc.gov/GAPPKB/phgHome.do




Last Posted: Apr 06, 2017

---

• Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease.  
  Spratt Daniel E et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Mar JCO2016702811
• A comparison of genetic risk score with family history for estimating prostate cancer risk.  
  Helfand Brian T et al. Asian journal of andrology 18(4) 515-9
• Genomic tests to guide prostate cancer management following diagnosis.  
  Colicchia Michele et al. Expert review of molecular diagnostics 2017 Mar 1-11
• Characterisation of microbial communities within aggressive prostate cancer tissues.  
  Yow Melissa A et al. Infectious agents and cancer 2017 4
• Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer.  
  Lobo Jennifer M et al. Clinical genitourinary cancer 2016 Aug
• All men with metastatic prostate cancer should have genetic testing  
  KnowRidge, December 29, 2016
• Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda. 
  Hamilton Jada G et al. Journal of general internal medicine 2016 Dec
• Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study.  
  Gray Stacy W et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Dec JCO2016671503
• From genes to therapies -- Systems Medicine of Neuro Endocrine Prostate Cancer - Beyond the Abstract  
  K Rehman, Uro Today, November 2016
• From genes to therapies -- Systems Medicine of Neuro Endocrine Prostate Cancer - Beyond the Abstract  
  K Rehman, Uro Today, November 2016
• Health Economic Impact and Prospective Clinical Utility of Oncotype DX® Genomic Prostate Score.  
  Albala David et al. Reviews in urology 2016 18(3) 123-132
• Differences in survival for patients with familial and sporadic cancer.  
  Lee Myeongjee et al. International journal of cancer 2016 Oct
• Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.  
  Lalonde Emilie et al. European urology 2016 Nov
• Should we Perform Genetic Testing on Men with Metastatic Prostate Cancer?  
  Mikropoulos C et al. Clinical oncology (Royal College of Radiologists (Great Britain)) 2016 Oct
• Prevention and Screening in Hereditary Breast and Ovarian Cancer.  
  Zeichner Simon B et al. Oncology (Williston Park, N.Y.) 2016 Oct 30(10)
• Common cancers share familial susceptibility: implications for cancer genetics and counselling.  
  Yu Hongyao et al. Journal of medical genetics 2016 Sep

more